ArticleOncotarget2016

Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma.

Eric W Prince et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.